The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with neoadjuvant versus adjuvant chemotherapy for T1-2 node negative triple negative breast cancer.
 
Priyanka Sharma
Research Funding - Cook Medical (I); GlaxoSmithKline; Myriad Genetics; NinePoint Medical (I); Olympus (I); Roche/Genentech
Travel, Accommodations, Expenses - Novartis
 
Bruce F. Kimler
No Relationships to Disclose
 
Jennifer R. Klemp
Honoraria - Myriad Genetics; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - I am the founder and CEO of Cancer Survivorship Training, Inc., an online learing company for healthcare providers. The company is the 23rd start-up at the Univ of Kansas and have a license agreement with KU for utilization of my IP.
 
Claire Ward
No Relationships to Disclose
 
Carol Sue Connor
No Relationships to Disclose
 
Marilee McGinness
No Relationships to Disclose
 
Joshua Matthew Varghise Mammen
No Relationships to Disclose
 
Jamie Lynn Wagner
No Relationships to Disclose
 
Amanda Leigh Amin
No Relationships to Disclose
 
Carol J. Fabian
Research Funding - Novartis (Inst)
 
Roy A. Jensen
No Relationships to Disclose
 
Andrew K. Godwin
No Relationships to Disclose
 
Qamar J. Khan
Research Funding - AstraZeneca; BiPar Sciences; GlaxoSmithKline; Novartis